Back to Report Store Home

ADHD therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations

  • Published: Jul-2014
  • Report Code: GBIHC337MR
  • Report Format: pdf

Description

List of Figures

Figure 1: ADHD Treatment Algorithm

Figure 2: ADHD Therapeutics Market, Marketed Products, Heat Map, 2013

Figure 3: ADHD Therapeutics Market, Global, Pipeline (%), 2013

Figure 4: ADHD Therapeutics Market, Global, Pipeline Distribution by Mechanism of Action and Program Type, 2013

Figure 5: ADHD Therapeutics Market, Global, Pipeline Distribution by Mechanism of Action (Tier 1) and Stage of Development, 2013

Figure 6: ADHD Therapeutics Market, Global, Pipeline Distribution by Mechanism of Action (Tier 2) and Stage of Development, 2013

Figure 7: ADHD Therapeutics Market, Global, Pipeline, Attrition Rate (%), 2013

Figure 8: ADHD Therapeutics Market, Global, Attrition Rate by Mechanism of Action (%), 2013

Figure 9: ADHD Therapeutics Market, Global, Pipeline, Clinical Trial Duration (months), 2013

Figure 10: ADHD Therapeutics Market, Global, Pipeline, Clinical Trial Duration by Mechanism (months), 2013

Figure 11: ADHD Therapeutics Market, Global, Pipeline, Clinical Trial Size, 2013

Figure 12: ADHD Therapeutics Market, Global, Pipeline, Clinical Trial Size per Product by Mechanism of Action, 2013

Figure 13: ADHD Therapeutics Market, Global, Pipeline, Size by Clinical Trial by Mechanism of Action, 2013

Figure 14: ADHD Therapeutics Market, Global, Pipeline, Mechanism of Action Heat Map, 2013

Figure 15: ADHD Therapeutics Market, Global, Sales Forecast for Edivoxetine ($m), 2016–2020

Figure 16: ADHD Therapeutics Market, Global, Sales Forecast for Metadoxine ER ($m), 2017–2020

Figure 17: ADHD Therapeutics Market, Global, Sales Forecast for SPN-812 ($m), 2019–2020

Figure 18: ADHD Therapeutics Market, Promising Pipeline Molecules, Heat Map

Figure 19: ADHD Therapeutics Market, Marketed Products, Heat Map, 2013

Figure 20: ADHD Therapeutics Market, Global, Treatment Patterns (million), 2013–2020

Figure 21: ADHD Therapeutics Market, Global, Market Size ($bn), 2013–2020

Figure 22: ADHD Therapeutics Market, Global, 2013–2020

Figure 23: ADHD Therapeutics Market, North America, Treatment Patterns, 2013–2020

Figure 24: ADHD Therapeutics Market, North America, Annual Cost of Treatment ($), 2013–2020

Figure 25: ADHD Therapeutics Market, North America, Market Size ($m), 2013–2020

Figure 26: ADHD Therapeutics Market, Top Five EU Countries, Treatment Patterns, 2013–2020

Figure 27: ADHD Therapeutics Market, Top Five EU Countries, Annual Cost of Treatment ($), 2013–2020

Figure 28: ADHD Therapeutics Market, Top Five EU Countries, Market Size ($m), 2013–2020

Figure 29: ADHD Therapeutics Market, Japan, 2013–2020

Figure 30: ADHD Therapeutics Market, Global, Major Licensing Deals by Year and Value, 2006–2014

Figure 31: ADHD Therapeutics Market, Global, Major Licensing Deals, 2006–2014

Figure 32: ADHD Therapeutics Market, Global, Major Co-developments Distribution, 2006–2014

Figure 33: ADHD Therapeutics Market, Global, Major Co-developments by Year and Phase, 2006–2014

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards